• 2023
  Bussotti G, Li B, Pescher P, Vojtkova B, Louradour I, Pruzinova K, Sadlova J, Volf P, Späth GF, Leishmania allelic selection during experimental sand fly infection correlates with mutational signatures of oxidative DNA damage., Proc Natl Acad Sci U S A 2023 Mar; 120(10): e2220828120.
• 2023
  Mano C, Kongkaew A, Tippawangkosol P, Somboon P, Roytrakul S, Pescher P, Späth GF, Uthaipibull C, Tantiworawit A, Siriyasatien P, Jariyapan N, Amphotericin B resistance correlates with increased fitness in vitro and in vivo in Leishmania (Mundinia) martiniquensis., Front Microbiol 2023 ; 14(): 1156061.
• 2022
  Piel L, Rajan KS, Bussotti G, Varet H, Legendre R, Proux C, Douché T, Giai-Gianetto Q, Chaze T, Cokelaer T, Vojtkova B, Gordon-Bar N, Doniger T, Cohen-Chalamish S, Rengaraj P, Besse C, Boland A, Sadlova J, Deleuze JF, Matondo M, Unger R, Volf P, Michaeli S, Pescher P, Späth GF, Experimental evolution links post-transcriptional regulation to Leishmania fitness gain., PLoS Pathog 2022 Mar; 18(3): e1010375.
• 2021
  Bussotti G, Piel L, Pescher P, Domagalska MA, Rajan KS, Cohen-Chalamish S, Doniger T, Hiregange DG, Myler PJ, Unger R, Michaeli S, Späth GF, , Genome instability drives epistatic adaptation in the human pathogen Leishmania., Proc Natl Acad Sci U S A 2021 12; 118(51): .
• 2020
  Rosazza T, Lecoeur H, Blisnick T, Moya-Nilges M, Pescher P, Bastin P, Prina E, Späth GF, , Dynamic imaging reveals surface exposure of virulent Leishmania amastigotes during pyroptosis of infected macrophages., J Cell Sci 2020 06; 134(5): .
• 2020
  Smirlis D, Dingli F, Pescher P, Prina E, Loew D, Rachidi N, Späth GF, , SILAC-based quantitative proteomics reveals pleiotropic, phenotypic modulation in primary murine macrophages infected with the protozoan pathogen Leishmania donovani., J Proteomics 2020 02; 213(): 103617.
• 2018
  Liburkin-Dan T, Schlisselberg D, Fischer-Weinberger R, Pescher P, Inbar E, Ephros M, Rentsch D, Späth GF, Zilberstein D, Stage-specific expression of the proline-alanine transporter in the human pathogen Leishmania, Mol. Biochem. Parasitol. 2018 06;222:1-5.
• 2018
  Piel L, Pescher P, Späth GF, , Reverse Epidemiology: An Experimental Framework to Drive Leishmania Biomarker Discovery in situ by Functional Genetic Screening Using Relevant Animal Models., Front Cell Infect Microbiol 2018 ; 8(): 325.
• 2017
  Prieto Barja P, Pescher P, Bussotti G, Dumetz F, Imamura H, Kedra D, Domagalska M, Chaumeau V, Himmelbauer H, Pages M, Sterkers Y, Dujardin JC, Notredame C, Späth GF, Haplotype selection as an adaptive mechanism in the protozoan pathogen Leishmania donovani, Nat Ecol Evol 2017 Dec;1(12):1961-1969.
• 2017
  Melo GD, Goyard S, Lecoeur H, Rouault E, Pescher P, Fiette L, Boissonnas A, Minoprio P, Lang T, New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence, PLoS Negl Trop Dis 2017 09;11(9):e0005924.
• 2017
  Dumetz F, Imamura H, Sanders M, Seblova V, Myskova J, Pescher P, Vanaerschot M, Meehan CJ, Cuypers B, De Muylder G, Späth GF, Bussotti G, Vermeesch JR, Berriman M, Cotton JA, Volf P, Dujardin JC, Domagalska MA, Modulation of Aneuploidy in during Adaptation to Different and Environments and Its Impact on Gene Expression, mBio 2017 05;8(3).
• 2016
  Yau WL, Lambertz U, Colineau L, Pescher P, MacDonald A, Zander D, Retzlaff S, Eick J, Reiner NE, Clos J, Späth GF, Phenotypic Characterization of a Leishmania donovani Cyclophilin 40 Null Mutant, J. Eukaryot. Microbiol. 2016 11;63(6):823-833.
• 2014
  Rachidi N, Taly JF, Durieu E, Leclercq O, Aulner N, Prina E, Pescher P, Notredame C, Meijer L, Späth GF, , Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection., Antimicrob Agents Chemother 2014 ; 58(3): 1501-15.
• 2011
  Mani J, Güttinger A, Schimanski B, Heller M, Acosta-Serrano A, Pescher P, Späth G, Roditi I, Alba-domain proteins of Trypanosoma brucei are cytoplasmic RNA-binding proteins that interact with the translation machinery, PLoS ONE 2011;6(7):e22463.
• 2011
  Pescher P, Blisnick T, Bastin P, Späth GF, Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation, Cell. Microbiol. 2011 Jul;13(7):978-91.
• 2011
  Forestier CL, Machu C, Loussert C, Pescher P, Späth GF, Imaging host cell-Leishmania interaction dynamics implicates parasite motility, lysosome recruitment, and host cell wounding in the infection process, Cell Host Microbe 2011 Apr;9(4):319-30.
• 2010
  Hem S, Gherardini PF, Osorio y Fortéa J, Hourdel V, Morales MA, Watanabe R, Pescher P, Kuzyk MA, Smith D, Borchers CH, Zilberstein D, Helmer-Citterich M, Namane A, Späth GF, Identification of Leishmania-specific protein phosphorylation sites by LC-ESI-MS/MS and comparative genomics analyses, Proteomics 2010 Nov;10(21):3868-83.
• 2009
  Filipe-Santos O, Pescher P, Breart B, Lippuner C, Aebischer T, Glaichenhaus N, Späth GF, Bousso P, A dynamic map of antigen recognition by CD4 T cells at the site of Leishmania major infection, Cell Host Microbe 2009 Jul;6(1):23-33.
• 2005
  Balazuc AM, Lagranderie M, Chavarot P, Pescher P, Roseeuw E, Schacht E, Domurado D, Marchal G, In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver, Microbes Infect. 2005 Jun;7(7-8):969-75.
• 2005
  Domurado D, Balazuc AM, Lagranderie M, Pescher P, Chavarot P, Roseeuw E, Coessens V, Stern S, Schacht E, Marchal G, Targeted norfloxacin is active in vivo against persistent Mycobacterium bovis BCG, J Control Release 2005 Jan;101(1-3):343-5.
• 2003
  Flamant S, Lebastard M, Pescher P, Besmond C, Milon G, Marchal G, Enhanced cloning efficiency of mouse bone marrow macrophage progenitors correlates with increased content of CSF-1 receptor of their progeny at low oxygen tension, Microbes Infect. 2003 Oct;5(12):1064-9.
• 2003
  Flamant S, Pescher P, Lemercier B, Clément-Ziza M, Képès F, Fellous M, Milon G, Marchal G, Besmond C, Characterization of a putative type IV aminophospholipid transporter P-type ATPase, Mamm. Genome 2003 Jan;14(1):21-30.
• 2002
  N'guessan K, Dosso M, Marchal G, Chavarot P, Romain F, Pescher P, Edy , [Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model], Bull Soc Pathol Exot 2002 Nov;95(4):265-8.
• 2001
  Garapin A, Ma L, Pescher P, Lagranderie M, Marchal G, Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins, Vaccine 2001 Apr;19(20-22):2830-41.
• 2001
  Dussurget O, Stewart G, Neyrolles O, Pescher P, Young D, Marchal G, , Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase., Infect Immun 2001 Jan; 69(1): 529-33.
• 1999
  Romain F, Horn C, Pescher P, Namane A, Riviere M, Puzo G, Barzu O, Marchal G, Deglycosylation of the 45/47-kilodalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses, Infect. Immun. 1999 Nov;67(11):5567-72.
• 1996
  Horn C, Pescher P, Romain F, Marchal G, Characterization of murine monoclonal antibodies specific for the 45/47 kDa antigen complex (APA) of Mycobacterium tuberculosis, M. bovis and BCG, J. Immunol. Methods 1996 Oct;197(1-2):151-9.
• 1993
  Romain F, Augier J, Pescher P, Marchal G, Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria, Proc. Natl. Acad. Sci. U.S.A. 1993 Jun;90(11):5322-6.
• 1993
  Romain F, Laqueyrerie A, Militzer P, Pescher P, Chavarot P, Lagranderie M, Auregan G, Gheorghiu M, Marchal G, Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria, Infect. Immun. 1993 Feb;61(2):742-50.
• 1985
  Romain F, Versmisse E, Pescher P, Augier J, Preparation of tuberculin antigen L, Ann. Inst. Pasteur Microbiol. 1985 Sep-Oct;136B(2):235-48.